Mersana Therapeutics, Inc.
MRSNDelisted Jan 6, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001442836
Mersana Therapeutics, Inc. was delisted on Jan 6, 2026; its insiders filed their last Form 4 on Jan 6, 2026; 51 institutions reported holding it in 13F filings for Q4 2025, worth $64.8M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Mersana Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 106 | 125 | +19 |
| Shares | 113.3M | 117.5M | +4.20M (+3.7%) |
| Value | $263.0M | $526.3M | +$263.3M (+100.1%) |
New holders (38)
Institutions that held Mersana Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (19)
Institutions that held Mersana Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Philosophy Capital Management LLC | 1,264,567 | $2.93M |
| Readystate Asset Management LP | 295,038 | $684.5K |
| Foundations Investment Advisors, LLC | 102,000 | $344.8K |
| Amundi | 95,540 | $308.6K |
| HRT Financial LP | 105,815 | $245.0K |
| LPL Financial LLC | 76,694 | $177.9K |
| Harbor Capital Advisors, Inc. | 47,472 | $110.1K |
| Man Group plc | 44,600 | $103.5K |
| Engineers Gate Manager LP | 43,694 | $101.4K |
| AQR Capital Management LLC | 31,559 | $73.2K |
| Group One Trading, L.P. | 31,081 | $72.1K |
| Point72 Middle East FZE | 25,511 | $59.2K |
| Pale Fire Capital SE | 25,400 | $58.9K |
| Public Employees Retirement System of Ohio | 15,800 | $36.7K |
| Squarepoint Ops LLC | 13,668 | $31.7K |
| Bayesian Capital Management, LP | 11,900 | $27.6K |
| Graham Capital Management, L.P. | 11,811 | $27.4K |
| Quantbot Technologies LP | 10,945 | $25.4K |
| Advisory Services Network, LLC | 100 | $232 |